Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioventus (BVS) Net Income towards Common Stockholders (2020 - 2026)

Bioventus filings provide 5 years of Net Income towards Common Stockholders readings, the most recent being $17.3 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders changed N/A to $17.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.3 million, a N/A change, with the full-year FY2023 number at -$74.4 million, down 8.28% from a year prior.
  • Net Income towards Common Stockholders hit $17.3 million in Q4 2025 for Bioventus, up from $4.0 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $24.5 million in Q2 2021 to a low of -$74.4 million in Q2 2023.
  • Median Net Income towards Common Stockholders over the past 4 years was -$401000.0 (2022), compared with a mean of -$8.0 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: soared 133.91% in 2021 and later plummeted 93484.0% in 2022.
  • Bioventus' Net Income towards Common Stockholders stood at -$25000.0 in 2021, then plummeted by 93484.0% to -$23.4 million in 2022, then tumbled by 218.13% to -$74.4 million in 2023, then surged by 123.27% to $17.3 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were $17.3 million (Q4 2025), $4.0 million (Q3 2025), and $9.3 million (Q2 2025) per Business Quant data.